KPTI - Karyopharm: Ready For Liftoff?
"Injustice is relatively easy to bear; what stings is justice." - H.L. Mencken
Today, we revisit a promising "Busted IPO" we have not discussed in a couple of months. We revisit this name and talk about some recent events and upcoming potential catalysts in the paragraphs below.
Company Overview
Karyopharm Therapeutics (KPTI) is a Massachusetts-based clinical stage or "Tier 4" pharmaceutical company. The firm is focused on creating novel, first-in-class drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases. KPTI currently has a